Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A)

G. Alimena; E. Morra; M. Lazzarino; A. M. Liberati; E. Montefusco; D. Inveradi; P. Bernasconi; M. Mancini; F. Grignani; C. Bernasconi; F. Dianzani; F. Mandelli

doi:10.1016/0305-7372(88)90070-9

Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A)

G. Alimena, E. Morra, M. Lazzarino, A. M. Liberati, E. Montefusco, D. Inveradi, P. Bernasconi, M. Mancini, F. Grignani, C. Bernasconi, F. Dianzani, F. Mandelli

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	21-26
Number of pages	6
Journal	Cancer Treatment Reviews
Volume	15
Issue number	SUPPL. A
DOIs	https://doi.org/10.1016/0305-7372(88)90070-9
Publication status	Published - 1988

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/0305-7372(88)90070-9

Cite this

Alimena, G., Morra, E., Lazzarino, M., Liberati, A. M., Montefusco, E., Inveradi, D., Bernasconi, P., Mancini, M., Grignani, F., Bernasconi, C., Dianzani, F., & Mandelli, F. (1988). Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A). Cancer Treatment Reviews, 15(SUPPL. A), 21-26. https://doi.org/10.1016/0305-7372(88)90070-9

Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A). / Alimena, G.; Morra, E.; Lazzarino, M.; Liberati, A. M.; Montefusco, E.; Inveradi, D.; Bernasconi, P.; Mancini, M.; Grignani, F.; Bernasconi, C.; Dianzani, F.; Mandelli, F.

In: Cancer Treatment Reviews, Vol. 15, No. SUPPL. A, 1988, p. 21-26.

Research output: Contribution to journal › Article › peer-review

Alimena, G, Morra, E, Lazzarino, M, Liberati, AM, Montefusco, E, Inveradi, D, Bernasconi, P, Mancini, M, Grignani, F, Bernasconi, C, Dianzani, F & Mandelli, F 1988, 'Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A)', Cancer Treatment Reviews, vol. 15, no. SUPPL. A, pp. 21-26. https://doi.org/10.1016/0305-7372(88)90070-9

@article{6cb16a09e8ae4cf0af4307b2117f707c,

title = "Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A)",

author = "G. Alimena and E. Morra and M. Lazzarino and Liberati, {A. M.} and E. Montefusco and D. Inveradi and P. Bernasconi and M. Mancini and F. Grignani and C. Bernasconi and F. Dianzani and F. Mandelli",

year = "1988",

doi = "10.1016/0305-7372(88)90070-9",

language = "English",

volume = "15",

pages = "21--26",

journal = "Cancer Treatment Reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

number = "SUPPL. A",

}

TY - JOUR

T1 - Treatment of Ph′-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (INTRON A)

AU - Alimena, G.

AU - Morra, E.

AU - Lazzarino, M.

AU - Liberati, A. M.

AU - Montefusco, E.

AU - Inveradi, D.

AU - Bernasconi, P.

AU - Mancini, M.

AU - Grignani, F.

AU - Bernasconi, C.

AU - Dianzani, F.

AU - Mandelli, F.

PY - 1988

Y1 - 1988

UR - http://www.scopus.com/inward/record.url?scp=0023870053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023870053&partnerID=8YFLogxK

U2 - 10.1016/0305-7372(88)90070-9

DO - 10.1016/0305-7372(88)90070-9

M3 - Article

C2 - 3277708

AN - SCOPUS:0023870053

VL - 15

SP - 21

EP - 26

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - SUPPL. A

ER -